139 related articles for article (PubMed ID: 9891528)
1. Epidermal growth factor and its receptor as prognostic indicators in Chinese patients with pancreatic cancer.
Dong M; Nio Y; Guo KJ; Tamura K; Tian YL; Dong YT
Anticancer Res; 1998; 18(6B):4613-9. PubMed ID: 9891528
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance of epidermal growth factor and its receptor in human pancreatic cancer.
Uegaki K; Nio Y; Inoue Y; Minari Y; Sato Y; Song MM; Dong M; Tamura K
Anticancer Res; 1997; 17(5B):3841-7. PubMed ID: 9427790
[TBL] [Abstract][Full Text] [Related]
3. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
4. Significance of urinary epidermal growth factor and its receptor expression in human bladder cancer.
Chow NH; Liu HS; Lee EI; Chang CJ; Chan SH; Cheng HL; Tzai TS; Lin JS
Anticancer Res; 1997; 17(2B):1293-6. PubMed ID: 9137488
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor expression in human pancreatic cancer: Significance for liver metastasis.
Tobita K; Kijima H; Dowaki S; Kashiwagi H; Ohtani Y; Oida Y; Yamazaki H; Nakamura M; Ueyama Y; Tanaka M; Inokuchi S; Makuuchi H
Int J Mol Med; 2003 Mar; 11(3):305-9. PubMed ID: 12579331
[TBL] [Abstract][Full Text] [Related]
6. Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness.
Yamanaka Y; Friess H; Kobrin MS; Buchler M; Beger HG; Korc M
Anticancer Res; 1993; 13(3):565-9. PubMed ID: 8317885
[TBL] [Abstract][Full Text] [Related]
7. Significance of cellular distribution of ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma.
Yeh TS; Tseng JH; Liu NJ; Chen TC; Jan YY; Chen MF
Arch Surg; 2005 Dec; 140(12):1184-90. PubMed ID: 16365240
[TBL] [Abstract][Full Text] [Related]
8. Expression of EGF and EGFR strongly correlates with metastasis of pancreatic ductal carcinoma.
Pryczynicz A; GuziĆska-Ustymowicz K; Kemona A; Czyzewska J
Anticancer Res; 2008; 28(2B):1399-404. PubMed ID: 18505086
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of EGF receptor expression in early glottic cancer.
Demiral AN; Sarioglu S; Birlik B; Sen M; Kinay M
Auris Nasus Larynx; 2004 Dec; 31(4):417-24. PubMed ID: 15571917
[TBL] [Abstract][Full Text] [Related]
10. Tissue status of epidermal growth factor and its receptor as an indicator of poor prognosis in patients with gastric cancer.
Yonemura Y; Sugiyama K; Fushida S; Kamata T; Ohoyama S; Kimura H; Yamaguchi A; Miyazaki I
Anal Cell Pathol; 1991 Nov; 3(6):343-50. PubMed ID: 1751401
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications.
Popov Z; Gil-Diez-De-Medina S; Ravery V; Hoznek A; Bastuji-Garin S; Lefrere-Belda MA; Abbou CC; Chopin DK
Urol Oncol; 2004; 22(2):93-101. PubMed ID: 15082004
[TBL] [Abstract][Full Text] [Related]
12. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours.
Monteiro LS; Bento MJ; Palmeira C; Lopes C
J Oral Pathol Med; 2009 Jul; 38(6):508-13. PubMed ID: 19317849
[TBL] [Abstract][Full Text] [Related]
14. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.
Chung CH; Ely K; McGavran L; Varella-Garcia M; Parker J; Parker N; Jarrett C; Carter J; Murphy BA; Netterville J; Burkey BB; Sinard R; Cmelak A; Levy S; Yarbrough WG; Slebos RJ; Hirsch FR
J Clin Oncol; 2006 Sep; 24(25):4170-6. PubMed ID: 16943533
[TBL] [Abstract][Full Text] [Related]
15. COX-2 expression in hepatocellular carcinoma is an initiation event; while EGF receptor expression with downstream pathway activation is a prognostic predictor of survival.
Foster J; Black J; LeVea C; Khoury T; Kuvshinoff B; Javle M; Gibbs JF
Ann Surg Oncol; 2007 Feb; 14(2):752-8. PubMed ID: 17146741
[TBL] [Abstract][Full Text] [Related]
16. Expression of c-erbB-2 oncogene protein, epidermal growth factor receptor, and TGF-beta1 in human pancreatic ductal adenocarcinoma.
Zhang L; Yuan SZ
Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):620-3. PubMed ID: 14607699
[TBL] [Abstract][Full Text] [Related]
17. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients.
Lieto E; Ferraraccio F; Orditura M; Castellano P; Mura AL; Pinto M; Zamboli A; De Vita F; Galizia G
Ann Surg Oncol; 2008 Jan; 15(1):69-79. PubMed ID: 17896140
[TBL] [Abstract][Full Text] [Related]
18. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
Steinman S; Wang J; Bourne P; Yang Q; Tang P
Ann Clin Lab Sci; 2007; 37(2):127-34. PubMed ID: 17522367
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies.
Scartozzi M; Bearzi I; Berardi R; Mandolesi A; Fabris G; Cascinu S
J Clin Oncol; 2004 Dec; 22(23):4772-8. PubMed ID: 15570078
[TBL] [Abstract][Full Text] [Related]
20. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]